Tim Higenbottam

14.6k total citations · 4 hit papers
190 papers, 9.2k citations indexed

About

Tim Higenbottam is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Tim Higenbottam has authored 190 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Pulmonary and Respiratory Medicine, 70 papers in Physiology and 66 papers in Surgery. Recurrent topics in Tim Higenbottam's work include Transplantation: Methods and Outcomes (55 papers), Pulmonary Hypertension Research and Treatments (38 papers) and Asthma and respiratory diseases (38 papers). Tim Higenbottam is often cited by papers focused on Transplantation: Methods and Outcomes (55 papers), Pulmonary Hypertension Research and Treatments (38 papers) and Asthma and respiratory diseases (38 papers). Tim Higenbottam collaborates with scholars based in United Kingdom, Italy and United States. Tim Higenbottam's co-authors include J. Wallwork, Rachel Lowry, DS Postma, Jack Gibson, P. Vermeire, al et, Marc Decramer, P Paoletti, P Howard and J C Yernault and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Tim Higenbottam

187 papers receiving 8.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

1995 1.2k citations Tim Higenbottam et al. European Respiratory Journal profile →
Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension

1996 813 citations Lucien Abenhaim, Yola Moride et al. New England Journal of Medicine profile →
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.

1993 604 citations Tim Higenbottam et al. PubMed profile →
ANGIOTENSIN-CONVERTING ENZYME AND THE COUGH REFLEX

1987 560 citations Tim Higenbottam et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Tim Higenbottam	6.0k	2.6k	2.4k	1.5k	1.1k	190	9.2k
Steven Kesten	9.4k 1.6×	6.1k 2.3×	1.7k 0.7×	660 0.5×	877 0.8×	192	11.7k
Nicolaos E. Madias	4.7k 0.8×	1.2k 0.5×	1.9k 0.8×	1.6k 1.1×	977 0.9×	155	11.2k
Robert R. Sciacca	2.5k 0.4×	1.1k 0.4×	2.0k 0.8×	4.5k 3.0×	2.1k 1.9×	240	13.2k
Francesca Mallamaci	2.2k 0.4×	2.7k 1.0×	3.1k 1.3×	6.1k 4.2×	2.0k 1.9×	349	15.4k
Olof Heimbürger	1.8k 0.3×	3.9k 1.5×	3.9k 1.6×	1.5k 1.0×	1.9k 1.8×	307	17.1k
Jan T. Kielstein	1.2k 0.2×	2.0k 0.8×	1.4k 0.6×	2.6k 1.8×	1.4k 1.3×	278	10.2k
Joachim H. Ix	3.1k 0.5×	2.1k 0.8×	3.1k 1.3×	4.7k 3.2×	2.0k 1.8×	473	17.7k
Christian Combe	1.0k 0.2×	1.0k 0.4×	1.4k 0.6×	880 0.6×	1.2k 1.1×	338	10.3k
Ferràn Torres	3.0k 0.5×	1.4k 0.6×	2.0k 0.8×	1.7k 1.2×	2.8k 2.6×	248	11.1k
Peter Bárány	1.1k 0.2×	2.3k 0.9×	1.6k 0.6×	1.2k 0.8×	1.3k 1.2×	233	11.1k

Countries citing papers authored by Tim Higenbottam

Since Specialization

Citations

This map shows the geographic impact of Tim Higenbottam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Higenbottam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Higenbottam more than expected).

Fields of papers citing papers by Tim Higenbottam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Higenbottam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Higenbottam. The network helps show where Tim Higenbottam may publish in the future.

Co-authorship network of co-authors of Tim Higenbottam

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Higenbottam. A scholar is included among the top collaborators of Tim Higenbottam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Higenbottam. Tim Higenbottam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zielen, Stefan, Piotr Kuna, Werner Aberer, et al.. (2019). Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing. World Allergy Organization Journal. 12(11). 100075–100075. 13 indexed citations

Wedzicha, Jadwiga A., Paul Jones, Géraldine Cohuet, et al.. (2012). A trial of beclomethasone/formoterol in COPD using EXACT-PRO to measure exacerbations. European Respiratory Journal. 41(1). 12–17. 27 indexed citations

Kudoh, Shoji, Harubumi Kato, Yutaka Nishiwaki, et al.. (2008). Interstitial Lung Disease in Japanese Patients with Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 177(12). 1348–1357. 365 indexed citations

Jones, Peter M. & Tim Higenbottam. (2007). Quantifying of Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: Adaptations to the Definition to Allow Quantification. Proceedings of the American Thoracic Society. 4(8). 597–601. 24 indexed citations

Hallberg, Jenny, Ulrika K. Eriksson, Maria Gerhardsson de Verdier, et al.. (2007). Interaction between Smoking and Genetic Factors in the Development of Chronic Bronchitis. American Journal of Respiratory and Critical Care Medicine. 177(5). 486–490. 38 indexed citations

Smith, Adrian, Eric Demoncheaux, & Tim Higenbottam. (2002). Nitric Oxide Gas Decreases Endothelin-1 mRNA in Cultured Pulmonary Artery Endothelial Cells. Nitric Oxide. 6(2). 153–159. 27 indexed citations

Higenbottam, Tim, et al.. (2001). The direct and indirect action of inhaled agents on the lung and its circulation: lessons for clinical science.. Environmental Health Perspectives. 109(suppl 4). 559–562. 10 indexed citations

Roca, Josep, Brian J. Whipp, Àlvar Agustí, et al.. (1997). Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. ERS Task Force on Standardization of Clinical Exercise Testing. European Respiratory Society. European Respiratory Journal. 10(11). 2662–2689. 243 indexed citations

Voelkel, N. F., William R. Clarke, & Tim Higenbottam. (1997). Obesity, Dexfenfluramine, and Pulmonary Hypertension. A Lesson Not Learned?. American Journal of Respiratory and Critical Care Medicine. 155(3). 786–788. 19 indexed citations

10.

Borland, Colin, et al.. (1996). Reduction of pulmonary capillary blood volume in patients with severe unexplained pulmonary hypertension.. Thorax. 51(8). 855–856. 24 indexed citations

11.

Abenhaim, Lucien, Yola Moride, François Brenot, et al.. (1996). Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension. New England Journal of Medicine. 335(9). 609–616. 813 indexed citations breakdown →

12.

Tamm, M., Tim Higenbottam, C. Dennis, Linda Sharples, & J. Wallwork. (1994). Donor and Recipient Predicted Lung Volume and Lung Size After Heart-Lung Transplantation. American Journal of Respiratory and Critical Care Medicine. 150(2). 403–407. 31 indexed citations

13.

Twentyman, Orion P. & Tim Higenbottam. (1992). Controversies in respiratory medicine: regular inhaled β-agonists — clearclinical benefit or a hazard to health?. Respiratory Medicine. 86(6). 471–476. 4 indexed citations

14.

Higenbottam, Tim, D.W. Bethune, R Cory-Pearce, et al.. (1988). Selection and procurement of combined heart and lung grafts for transplantation. Journal of Thoracic and Cardiovascular Surgery. 95(3). 474–479. 70 indexed citations

15.

Penketh, A, Tim Higenbottam, M Hakim, & J. Wallwork. (1987). Heart and lung transplantation in patients with end stage lung disease.. BMJ. 295(6593). 311–314. 47 indexed citations

16.

Wallwork, J., et al.. (1986). Serious interaction between cyclosporin A and sulphadimidine.. BMJ. 292(6522). 728–729. 23 indexed citations

17.

Borland, Colin & Tim Higenbottam. (1985). Do the oxides of nitrogen in cigarette smoke cause emphysema in smokers?. PubMed. 10(4). 371–3. 2 indexed citations

18.

Borland, Colin, et al.. (1985). Pulmonary Epithelial Permeability after Inhaling Saline, Distilled Water “Fog” and Cold Air*. CHEST Journal. 87(3). 373–376. 9 indexed citations

19.

Higenbottam, Tim, et al.. (1983). Bronchial reactivity in asthmatic adults with normal spirometric values.. BMJ. 286(6370). 1012–1014. 19 indexed citations

20.

McGregor, C G, et al.. (1983). Variable intrathoracic airways obstruction masquerading as asthma.. BMJ. 287(6403). 1457–1458. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact